Literature DB >> 22710347

Targeting mitochondria in the infection strategy of the hepatitis C virus.

Giovanni Quarato1, Rosella Scrima, Francesca Agriesti, Darius Moradpour, Nazzareno Capitanio, Claudia Piccoli.   

Abstract

Hepatitis C virus (HCV) infection induces a state of oxidative stress more pronounced than that observed in many other inflammatory diseases. Here, we propose a temporal sequence of events in the HCV-infected cell whereby the primary alteration consists of a release of Ca(2+) from the endoplasmic reticulum, followed by uptake into mitochondria. This ensues successive mitochondrial dysfunction leading to the generation of reactive oxygen species and a progressive metabolic adaptive response. Evidence is provided for a positive feed-back mechanism between alterations of calcium and redox homeostasis. This likely involves deregulation of the mitochondrial permeability transition and induces progressive dysfunction of cellular bioenergetics. Pathogenetic implications of the model and new opportunities for therapeutic intervention are discussed. This article is part of a Directed Issue entitled: Bioenergetic dysfunction, adaptation and therapy.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710347     DOI: 10.1016/j.biocel.2012.06.008

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  13 in total

1.  Sigma-1 receptor regulates early steps of viral RNA replication at the onset of hepatitis C virus infection.

Authors:  Martina Friesland; Lidia Mingorance; Josan Chung; Francis V Chisari; Pablo Gastaminza
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

Review 2.  Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.

Authors:  Alla Arzumanyan; Helena M G P V Reis; Mark A Feitelson
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

3.  Activity increase in respiratory chain complexes by rubella virus with marginal induction of oxidative stress.

Authors:  C Claus; K Schönefeld; D Hübner; S Chey; U Reibetanz; U G Liebert
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

Review 4.  Hepatitis C virus, mitochondria and auto/mitophagy: exploiting a host defense mechanism.

Authors:  Vitalba Ruggieri; Carmela Mazzoccoli; Valerio Pazienza; Angelo Andriulli; Nazzareno Capitanio; Claudia Piccoli
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

5.  Mitochondrial dysfunction in rabies virus infection of neurons.

Authors:  Thamir Alandijany; Wafa Kammouni; Subir K Roy Chowdhury; Paul Fernyhough; Alan C Jackson
Journal:  J Neurovirol       Date:  2013-11-26       Impact factor: 2.643

6.  Rabies virus phosphoprotein interacts with mitochondrial Complex I and induces mitochondrial dysfunction and oxidative stress.

Authors:  Wafa Kammouni; Heidi Wood; Ali Saleh; Camila M Appolinario; Paul Fernyhough; Alan C Jackson
Journal:  J Neurovirol       Date:  2015-02-20       Impact factor: 3.739

7.  Enterovirus 71 induces mitochondrial reactive oxygen species generation that is required for efficient replication.

Authors:  Mei-Ling Cheng; Shiue-Fen Weng; Chih-Hao Kuo; Hung-Yao Ho
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

8.  CSFV induced mitochondrial fission and mitophagy to inhibit apoptosis.

Authors:  Hongchao Gou; Mingqiu Zhao; Hailuan Xu; Jin Yuan; Wencheng He; Mengjiao Zhu; Hongxing Ding; Lin Yi; Jinding Chen
Journal:  Oncotarget       Date:  2017-06-13

9.  Oxidative status and the response to pegylated-interferon alpha2a plus ribavirin in chronic genotype 4 HCV hepatitis.

Authors:  Mohammed Mahmound Ahmed; Omar M E Abdel-Salam; Nadia A Mohammed; Dawoud Fakhry Habib; Hewida Ez-Eldin Gomaa
Journal:  EXCLI J       Date:  2013-07-02       Impact factor: 4.068

10.  Targeting Endoplasmic Reticulum and/or Mitochondrial Ca2+ Fluxes as Therapeutic Strategy for HCV Infection.

Authors:  Rosella Scrima; Claudia Piccoli; Darius Moradpour; Nazzareno Capitanio
Journal:  Front Chem       Date:  2018-03-21       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.